300+ cases of multidrug-resistant shigella seen in US, Europe since April

Since April, 309 cases of shigellosis have been reported to the European Centre for Disease Prevention and Control, including 106 in the U.S. Most of the cases were caused by multidrug-resistant strains of the shigella bacteria, with transmission primarily seen among men who have sex with men.

Advertisement

The cases are linked to seven “distinct microbiologic clusters” in Belgium (26), Denmark (13), Germany (33), Ireland (50), the Netherlands (21), Spain (60) and the U.S. (106).

“All strains in these seven clusters show resistance to first and second-line antibiotics, such as third-generation cephalosporin, fluoroquinolones, sulfamethoxazole, and trimethoprim. Of particular concern is resistance to azithromycin in some of the strains related to these clusters, as this limits the options for effective treatment,” the agency said in a July 18 epidemiological update. 

Shigellosis is a gastrointestinal infection usually contracted by ingesting contaminated food and water. Read more here.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.